Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Pseudomyxoma Peritonei × Bromelains × Clear all

Phase

Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Pseudomyxoma Peritonei 1

Interventions

irinotecan sucrosofate 1 Radiosurgery 1 Pharmacogenomic Testing 1 Oxaliplatin 1 Leucovorin 1 Gemcitabine 1 Floxuridine 1 Carboplatin 1 Bromelains 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04982146 2022-06-02

Intratumoral Bromelain + Acetylcysteine in Relapsed and Unresectable Pseudomyxoma Peritonei

Maimónides Biomedical Research Institute of Córdoba

Phase 1 Unknown

Pseudomyxoma Peritonei

Data powered by HemOnc (CC BY 4.0) Colophon ⚡